Hoebel and researchers in the department of psychology and the Princeton Neuroscience Institute have demonstrated patterns of craving and relapse, the third and final stage of addiction, that had ...
Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...
Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...
Dr. Harriet de Wit's groundbreaking 45-year journey bridges animal and human drug research, reshaping global understanding of consciousness CHICAGO, Illinois, USA, 26 August 2025 -- In a revealing ...
Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs. By Jan Hoffman The message ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Share on Pinterest A growing body of evidence suggests that GLP-1 drugs prescribed for obesity and diabetes could also help treat addiction. FreshSplash/Getty Images GLP-1 drugs like Ozempic and ...
“Ozempic personality” is a side effect reported by some users of popular GLP-1 obesity and diabetes medications. The term refers to a cluster of mental health issues, including increased anxiety, ...
SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback